COVID-19 Informational Resource Page (Updated 12/08/20; 11:00A)

The Virginia MGMA has created this page as a resource for medical practice management professionals regarding COVID-19. It includes current information, webinars, articles, documents, links, etc. we are receiving on this rapidly changing situation. Our Corporate Sponsors have also submitted helpful information. Please check this page often for updates.
NOTE: VMGMA has not vetted these resources and recommends you consult your attorney or CPA before making any changes to how you conduct business. This page is for information only.             

(12/16/20); 1:00P CMS Final Rules for 2021 (Register HERE)
Sponsored by VMGMA Bronze Corporate Sponsor RxVantage
This webinar will feature Bobbi Buell as she unpacks the CMS final rules (both physician and hospital outpatient), covers the E/M changes for 2021, and Most Favored Nation drug pricing and how it will affect billing in the new year.


TOPIC: Getting Practices Back to ‘Normal’: HR Best Practices and Legal Compliance Issues  
Presented by Curi, VMGMA Bronze Corporate Sponsor.
Provided by RxVantage, VMGMA Bronze Corporate Sponsor
Click HERE
In this succinct, 15-minute webinar, we share trends, protocols, and sample policy changes thousands of medical practices have made in response to COVID-19.

How to "See" Patients during a Pandemic - and Get Paid For It  LINK
Presented by SR Health. Questions or comments? Contact Erik Kingston at: [email protected]
SPEAKER: Elizabeth Woodcock, MBA, FACMPE, CPC is the principal of Woodcock & Associates
COVID-19 has facilitated sweeping changes to the healthcare system; overnight, healthcare organizations have been forced to pivot their ambulatory enterprises from office-based care sites to treating patients remotely. Innovation, speed, and dedication have been embraced for this successful transformation. Join Elizabeth Woodcock for advice about ensuring that your successful operations incorporate the financial aspects of remote care. You’ll learn about:

- Necessary alterations to your scheduling and registration workflows
- Reimbursement opportunities for remote care
- Differences between telemedicine and virtual services
Don’t miss your chance to get these expert insights and ask your questions about providing virtual care and how to get paid for it.

Webinar Series: Healthcare Practice Comeback
Presented by SolutionReach. Questions or comments? Contact Lori Curtis <[email protected]>
How does your practice bounce back from COVID-19? Here's our plan to get you back in the game - ideas for communication, preparation, and things you can do RIGHT NOW. Everyone loves a good comeback story. Let's start writing yours.

The Practice Comeback Plan webinar series includes four one-hour sessions.
Series Breakdown: Link
Session 1: Practice Comeback Plan Overview
Session 2: Urgent - "Do This Now"
Session 3: Recovery - "Ready to Reopen"
Session 4: Growth "Thrive Going Forward" 

Staying Connected in an Isolated World
SPEAKER: Greg Peters, The Reluctant Networker
Shared by IL / MI MGMA
Recording /
Access Password
: @connect1 / PPT

Leading Change Through Turmoil & Turbulence for Practice Managers
Mary Kelly, Productive Leaders
Webinar Recording
Handouts: 5 Minute Brainstorming Plan; 5 Minute Daily Productive Plan; 5 Minute Focus Plan

VMGMA 2020 Corporate Sponsor Resources

McKesson Medical Surgical
-  Webinar: COVID-19 Trends Impacting Providers, powered by Avalere
-  Webinar: Preparing for the New Normal: Virtualizing Medical Care Post Pandemic, brought to you by Amwell
Webinar Wednesday Page: Complete form on right of screen to be alerted to upcoming webinars
-  McKesson Medical-Surgical Covid-19 Support Portal
- FAQ For Policy Holders & Helpful Information
- COVID-19 Article
- Blog Post: Combating Burnout During the Ongoing Pandemic
- Blog Post: 7 Books for Managers to Read During COVID and Beyond
- Blog Post: Message Reps Individually or in Groups
- Updated "Reopening Playbook" with more resources and insights for practices navigating a new normal in vendor/rep communications.

- Safely Re-Opening Amid COVID-19 Vendor Rep. Visitation Protocol Update
- Sample Policy: COVID-19 Vendor/Rep Visitation Protocol Update
- Insight/Guidance on Vendor/Rep Visitation
(5/18/20) Contain Costs By Addressing Financial Barriers to Medication Adherence
(5/18/20) Building a Clinical Education Strategy
(5/18/20) 5 Ways to Boost Practice Efficiency on a Shoestring Budget
(5/18/20) COVID-19 & Medical Practices Updating Protocols For Rep Engagement
(5/18/20) Life Science Companies & Healthcare Providers Partnering for Value Based Patient Care
(5/18/20) 7 Free or Low Cost Ways to Increase Practice Efficiency

- Click HERE for COVID-19 information.
- Click HERE for MSVIA COVID-19 information.
- Click HERE for MSV COVID-19 information.
HandCraft Linen & Uniform Specialists
- Article: How To Reduce Contamination in Patient Rooms
- COVID-19 Resource PAGE
The Doctors Company
- COVID-19 Malpractice Coverage FAQ Page. Although it is written for TDC members, there is general information included as well.
- COVID-19 Resource Center
- Link to LabCorp Informational Page

Virginia Becomes First State to Adopt COVID-19-Related Workplace Health and Safety Standard
  (Lexology Article)
Virginia Department of Health: Click HERE
: Click HERE
US Department of Labor / Wage & Hour Division
   - Employee Rights Poster
   - Paid Sick Leave & Expanded Medical Leave Under FFCRA

Centers For Medicare & Medicaid Services (Philadelphia Regional Office)

To keep up with the important work the Task Force is doing in response to COVID-19, please click HERE. For a complete and updated list of CMS actions, guidance and other information in response to COVID-19, please visit the Current Emergencies Website.

(10/29/20)  Trump Administration Acts to Ensure Coverage of Life-Saving COVID-19 Vaccines & Therapeutics
CMS is taking steps to ensure all Americans, including the nation’s seniors, have access to the coronavirus disease 2019 (COVID-19) vaccine at no cost when it becomes available. On October 28, the agency released a comprehensive plan with proactive measures to remove regulatory barriers and ensure consistent coverage and payment for the administration of an eventual vaccine for millions of Americans. CMS released a set of toolkits for providers, states and insurers to help the health care system prepare to swiftly administer the vaccine once it is available. These resources are designed to increase the number of providers that can administer the vaccine, ensure adequate reimbursement for administering the vaccine in Medicare, while making it clear to private insurers and Medicaid programs their responsibility to cover the vaccine at no charge to beneficiaries. In addition, CMS is taking action to increase reimbursement for any new COVID-19 treatments that are approved or authorized by the FDA.
“Under President Trump’s leadership, we have developed a comprehensive plan to support the swift and successful distribution of a safe and effective vaccine for COVID-19,” said CMS Administrator Seema Verma. “As Operation Warp Speed nears its goal of delivering the vaccine in record time, CMS is acting now to remove bureaucratic barriers while ensuring that states, providers and health plans have the information and direction they need to ensure broad vaccine access and coverage for all Americans.”
To ensure broad access to a vaccine for America’s seniors, CMS released an Interim Final Rule with Comment Period (IFC) that establishes that any vaccine that receives Food and Drug Administration (FDA) authorization, either through an Emergency Use Authorization (EUA) or licensed under a Biologics License Application (BLA), will be covered under Medicare as a preventive vaccine at no cost to beneficiaries. The IFC also implements provisions of the CARES Act that ensure swift coverage of a COVID-19 vaccine by most private health insurance plans without cost sharing from both in and out-of-network providers during the course of the public health emergency (PHE).
In anticipation of the availability of new COVID-19 treatments, the IFC also establishes additional Medicare hospital payment to support Medicare patients’ access to these potentially life-saving COVID-19 therapies.  In Medicare, hospitals are generally reimbursed a fixed payment amount for the services they provide during an inpatient stay, even if their costs exceed that amount. Under current rules, hospitals may qualify for additional “outlier payments,” but only when their costs for a particular patient exceed a certain threshold. Under this IFC, hospitals would qualify for additional payments when they treat patients with innovative new products approved or authorized to treat COVID-19 to mitigate any losses they may experience from making these therapies available, even if they do not reach the current outlier threshold. The IFC also makes changes to reimbursement for outpatient hospital services to ensure payment for certain innovative treatments for COVID-19 that occur outside of bundled arrangements and are paid separately. In addition, CMS released information to prepare hospitals to bill for the outpatient administration of a monoclonal antibody product in the event one is approved under an emergency use authorization (EUA).
This rule also allows states to employ a broad range of strategies - based on local needs - to appropriately manage their Medicaid program costs. The guidance and flexibility provided to states in the IFC will help them maintain Medicaid beneficiary enrollment while receiving the temporary increase in federal funding in the Families First Coronavirus Response Act (FFCRA).
CMS is also taking continued steps to ensure that price transparency extends to COVID-19 testing during the PHE. Provisions in the IFC require that any provider who performs a COVID-19 diagnostic test post their cash prices online. Providers that are non-compliant may face civil monetary penalties.
In addition to these provisions, the IFC:
•    Provides an extension of Performance Year 5 for the Comprehensive Care for Joint Replacement (CJR) model; and
•    Creates flexibilities in the public notice requirements and post-award public participation requirements for a State Innovation Waiver under Section 1332 of the Patient Protection and Affordable Care Act during the COVID-19 PHE.
Along with these regulatory changes, CMS is issuing three toolkits aimed at state Medicaid agencies, providers who will administer the vaccine, and health insurance plans. Together, these toolkits will help ensure the health care system is prepared to successfully administer a safe and effective vaccine by addressing issues related to access, billing and payment, and coverage.
Increasing Access to Vaccines for Medicare & Medicaid Beneficiaries
The toolkits issued today give health care providers not currently enrolled in Medicare the information needed to administer and bill vaccines to Medicare patients. CMS is working to increase the number of providers that will administer a COVID-19 vaccine to Medicare beneficiaries when it becomes available, to make it as convenient as possible for America’s seniors. New providers are now able to enroll as a “Medicare mass immunizers” through an expedited 24-hour process. The ability to easily enroll as a mass immunizer is important for some pharmacies, schools, and other entities that may be non-traditional providers or otherwise not eligible for Medicare enrollment. To further increase the number of providers who can administer the COVID -19 vaccine, CMS will continue to share approved Medicare provider information with states to assist with Medicaid provider enrollment efforts. CMS is also making it easier for newly enrolled Medicare providers to also enroll in state Medicaid programs to support state administration of vaccines for Medicaid recipients.
As a condition of receiving free COVID-19 vaccines from the federal government, providers will be prohibited from charging consumers for administration of the vaccine. To ensure broad and consistent coverage across programs and payers, the toolkits have specific information for several programs, including:
Medicare: Beneficiaries with Medicare pay nothing for COVID-19 vaccines and their copayment/coinsurance and deductible are waived.
Medicare Advantage (MA): For calendar years 2020 and 2021, Medicare will pay directly for the COVID-19 vaccine and its administration for beneficiaries enrolled in MA plans. MA plans would not be responsible for reimbursing providers to administer the vaccine during this time. Medicare Advantage beneficiaries also pay nothing for COVID-19 vaccines and their copayment/coinsurance and deductible are waived.
Medicaid: State Medicaid and CHIP agencies must provide vaccine administration with no cost sharing for most beneficiaries during the public health emergency. Following the public health emergency, depending on the population, states may have to evaluate cost sharing policies and may have to submit state plan amendments if updates are needed.
Private Plans: CMS, along with the Departments of Labor and the Treasury, is requiring that most private health plans and issuers cover a recommended COVID-19 vaccine and its administration, both in-network and out-of-network, with no cost sharing. The rule also provides that out-of-network rates cannot be unreasonably low, and references CMS’s reimbursement rates as a potential guideline for insurance companies.
Uninsured: For individuals who are uninsured, providers will be able to be reimbursed for administering the COVID-19 vaccine to individuals without insurance through the Provider Relief Fund, administered by the Health Resources and Services Administration (HRSA).
Billing and Payment
The toolkits also address issues related to billing and payment. After the FDA either approves or authorizes a vaccine for COVID-19, CMS will identify the specific vaccine codes, by dose if necessary, and specific vaccine administration codes for each dose for Medicare payment. CMS and the American Medical Association (AMA) are working collaboratively on finalizing a new approach to report use of COVID-19 vaccines, which include separate vaccine-specific codes. Providers and insurance companies will be able to use these to bill for and track vaccinations for the different vaccines that are provided to their enrollees.
Medicare Payment
CMS also released new Medicare payment rates for COVID-19 vaccine administration. The Medicare payment rates will be $28.39 to administer single-dose vaccines. For a COVID-19 vaccine requiring a series of two or more doses, the initial dose(s) administration payment rate will be $16.94, and $28.39 for the administration of the final dose in the series. These rates will be geographically adjusted and recognize the costs involved in administering the vaccine, including the additional resources involved with required public health reporting, conducting important outreach and patient education, and spending additional time with patients answering any questions they may have about the vaccine. Medicare beneficiaries, those in Original Medicare or enrolled in Medicare Advantage, will be able to get the vaccine at no cost.
CMS is encouraging state policymakers and other private insurance agencies to utilize the information on the Medicare reimbursement strategy to develop their vaccine administration payment plan in the Medicaid program, CHIP, the Basic Health Program (BHP), and private plans. Using the Medicare strategy as a model would allow states to match federal efforts in successfully administering the full vaccine to the most vulnerable populations.
The IFC (CMS-9912-IFC) is scheduled to display at the Federal Register as soon as possible with an immediate effective date and a 30-day comment period.
For More Information:
•    Fact Sheet
•    COVID-19 vaccine resources for providers, health plans and State Medicaid programs
•    FAQs on billing for therapeutics
  Enforcement Discretion Relating to Certain Pharmacy Billing
The Centers for Medicare & Medicaid Services (“CMS”) appreciates its long-standing partnership with immunizers, including pharmacies, to facilitate the efficient administration of vaccinations, particularly for vulnerable populations in long-term care facilities and other congregate care settings across America. Leveraging immunizers’ capabilities and expertise will play an important role in the Department’s ability to broadly distribute and administer COVID-19 vaccinations, including Medicare beneficiaries.
America is facing an unprecedented challenge. Quickly, safely, and effectively vaccinating our most vulnerable citizens in settings that have accounted for about 30 percent of U.S. COVID-19 deaths is a top-priority mission for the Trump Administration. Unfortunately, many long-term care facilities may not have sufficient capacity to receive, store, and administer vaccines. And some long-term care facility residents cannot safely leave the facility to receive vaccinations.
Outside immunizers can help fill that urgent need and provide onsite vaccinations at skilled nursing facilities (“SNFs”). But to do so during this global emergency, Medicare-enrolled vaccinators must be able to bill directly and receive direct reimbursement from the Medicare program. However, the Social Security Act requires SNFs to bill for certain services, including vaccine administration, even when SNFs rely on an outside vendor to perform the service. See Social Security Act §§ 1862(a)(18), 1842(b)(6)(E).
Therefore, in order to facilitate the efficient administration of COVID-19 vaccines to SNF residents, CMS will exercise enforcement discretion with respect to these statutory provisions as well as any associated statutory references and implementing regulations, including as interpreted in pertinent guidance (collectively, “SNF Consolidated Billing Provisions”). Through the exercise of that discretion, CMS will allow Medicare-enrolled immunizers, including but not limited to pharmacies working with the United States, to bill directly and receive direct reimbursement from the Medicare program for vaccinating Medicare SNF residents.
CMS will exercise such discretion (1) during the emergency period defined in paragraph (1)(B) of section 1135(g) of the Social Security Act (42 U.S.C. § 1320b-5(g)) and ending on the last day of the calendar quarter in which the last day of such emergency period occurs; or (2) so long as CMS determines that there is a public health need for mass COVID-19 vaccinations in congregate care settings—whichever is later. While CMS exercises this enforcement discretion, compliance with SNF Consolidated Billing Provisions is not material to CMS’ decision to reimburse for COVID-19 vaccine administration. If CMS decides in the future to cease exercising this enforcement discretion, CMS will provide public notice in advance and allow at least 60 days for affected outside immunizers to modify their business practices.

(10/15/20) Trump Administration Drives Telehealth Services in Medicaid and Medicare
On October 14, CMS expanded the list of telehealth services that Medicare Fee-for-Service will pay for during the COVID-19 Public Health Emergency (PHE). CMS is also providing additional support to state Medicaid and Children’s Health Insurance Program (CHIP) agencies in their efforts to expand access to telehealth. The actions reinforce President Trump’s Executive Order on Improving Rural Health and Telehealth Access to improve the health of all Americans by increasing access to better care.
“Responding to President Trump’s Executive Order, CMS is taking action to increase telehealth adoption across the country,” said CMS Administrator Seema Verma. “Medicaid patients should not be forgotten, and today’s announcement promotes telehealth for them as well. This revolutionary method of improving access to care is transforming health care delivery in America. President Trump will not let the genie go back into the bottle.”
Expanding Medicare Telehealth Services:
For the first time using a new expedited process, CMS added 11 new services to the Medicare telehealth services list since the publication of the May 1 COVID-19 Interim Final Rule with comment period (IFC). Medicare will begin paying eligible practitioners who furnish these newly added telehealth services effective immediately and for the duration of the PHE. These new telehealth services include certain neurostimulator analysis and programming services, and cardiac and pulmonary rehabilitation services. The list of these newly added services is available on the List of Telehealth Services webpage.
In the May 1 COVID-19 IFC, CMS modified the process for adding or deleting services from the Medicare telehealth services list to allow for expedited consideration of additional telehealth services during the PHE outside of rulemaking. This update to the Medicare telehealth services list builds on the efforts CMS has already taken to increase Medicare beneficiaries’ access to telehealth services during the COVID-19 PHE.
Since the beginning of the PHE, CMS added over 135 services to the Medicare telehealth services list – such as emergency department visits, initial inpatient and nursing facility visits, and discharge day management services. With this action, Medicare will pay for 144 services performed via telehealth. Between mid-March and mid-August, over 12.1 million Medicare beneficiaries – over 36% – of people with Medicare Fee-for-Service received a telemedicine service.
Preliminary Medicaid and CHIP Data Snapshot on Telehealth Utilization and Medicaid & CHIP Telehealth Toolkit Supplement:
In an effort to provide greater transparency on telehealth access in Medicaid and CHIP, CMS released, for the first time, a preliminary Medicaid and CHIP data snapshot on telehealth utilization during the PHE. This snapshot shows, among other things, that there have been more than 34.5 million services delivered via telehealth to Medicaid and CHIP beneficiaries between March and June of this year, representing an increase of more than 2,600% when compared to the same period from the prior year. The data also shows that adults ages 19-64 received the most services delivered via telehealth, although there was substantial variance across both age groups and states.
To further drive telehealth, CMS released a new supplement to its State Medicaid & CHIP Telehealth Toolkit: Policy Considerations for States Expanding Use of Telehealth, COVID-19 Version that provides numerous new examples and insights into lessons learned from states that implemented telehealth changes. The updated supplemental information is intended to help states strategically think through how they explain and clarify to providers and other stakeholders which policies are temporary or permanent. It also helps states identify services that can be accessed through telehealth, which providers may deliver those services, the ways providers may use in order to deliver services through telehealth, as well as the circumstances under which telehealth can be reimbursed once the PHE expires.
The toolkit includes approaches and tools states can use to communicate with providers on utilizing telehealth for patient care. It updates and consolidates in one place the FAQs and resources for states to consider as they begin planning beyond the temporary flexibilities provided in response to the pandemic.

(10/13/20) CARES Act Provider Relief Fund: New Phase of Provider Relief Fund Opens for Applications
Providers are encouraged to apply for the latest round of Provider Relief Fund (PRF) support. Applications will be considered regardless of whether your organization was previously eligible for, applied for, received, accepted, or rejected prior PRF payments. For this newest phase, funding will be allocated to providers based on assessed financial losses and changes in operating expenses caused by COVID-19.  For more information about the Phase 3-General Distribution, please visit the Provider Relief Fund webpage.
Apply here through November 6

Repayment of Coronavirus Accelerated and Advance Payments
The recently enacted "Continuing Appropriations Act, 2021 and Other Extensions Act" amended the repayment terms for the Expanded Accelerated and Advance Payments (AAP) Program. Accordingly, repayment of any AAP will now begin one (1) year from the issuance date of the AAP. No action is necessary from providers. This repayment process will begin automatically. The repayment terms as amended by Congress are as follows:
- Repayment will begin one (1) year after the date the APP was issued.
- During the first eleven (11) months after repayment begins, repayment will occur through an automatic recoupment of twenty-five (25) percent of Medicare payments otherwise owed to the provider.
- During the succeeding six (6) months, repayment will occur through an automatic recoupment of fifty (50) percent of Medicare payments otherwise owed to the provider.
If a provider is unable to repay the total amount of the APP through recoupment within twenty-nine (29) months, the provider will receive a demand letter requiring repayment of any outstanding balance, subject to an interest rate of four (4) percent.
Palmetto GBA will issue letters to any provider or facility that received an APP with full details regarding repayment of their accelerated or advanced payment. The letter will include a list of the provider’s accelerated or advance payment(s), including the amount(s), the date(s) that repayment will begin, and the related Accounts Receivable (AR) number(s). If a provider received accelerated or advance payment(s) in multiple disbursements, each disbursement amount will be listed, along with the corresponding date that repayment for each disbursement will begin.



(10/2/20) HHS publishes reporting requirements for Provider Relief Funds
The Department of Health & Human Services (HHS) released additional guidance on reporting requirements for certain recipients of Provider Relief Fund payments. Group practices that received more than $10,000 in Provider Relief Fund payments must report on how they spent the funds on COVID-related expenses and lost revenue. There are more detailed reporting requirements for those that received $500,000 or more in payments.
According to the guidance, the reporting system will be available starting in early 2021, rather than in October 2020 as originally stated. Group practices should keep in mind that deadlines associated with the Provider Relief Fund have changed numerous times and any dates included in guidance are subject to change. This fact sheet provides a summary while more detailed guidance can be found here.

- MGMA COVID Action Center

- Article: 12 Steps For Keeping Your Medical Practice Running Amid COVID-19

- Article: Coronavirus Test Tracker - Commercially Available COVID-19 Diagnostic Tests


Virginia Department of Health: Click HERE
: Click HERE
US Department of Labor / Wage & Hour Division
   - Employee Rights Poster
   - Paid Sick Leave & Expanded Medical Leave Under FFCRA
AAD COVID-19 Reopening Guidelines
Politico Article: Health Care Workforce is Recession Proof. Is it "Pandemic Proof?"
 *VMGMA Legislative Liaison Gerard Filicko, CMPE, contributed to this article.
(4/8/20) Daily Labor Report Article - INSIGHT: Managing Health-Care Workers During Coronavirus
(4/6/20) PayCheck Protection Program (PPP) Information Sheet
Total Medical Compliance COVID-19 Resource Page
As a member of the Virginia healthcare community, you have likely seen information regarding Emergency Temporary Standard Infectious Disease Prevention: SARS-CoV-2 Virus that Causes COVID 19, which is now in effect. This new standard applies to all employers, employees, and places of employment in the Commonwealth of Virginia. Requirements include an assessment of exposure risk to the virus and specific measures each employer must implement based on the exposure risk level. Additional training and documentation requirements are clearly defined as well.
Total Medical Compliance, a nationwide leader in healthcare compliance, has been busy working reviewing the standard, and is already developing both the training and documentation your office will need to be compliant. Employers will have a relatively short time to comply with the August 26, 2020 training date. Be assured we will have the tools you need to meet the requirements of the standards by the established compliance dates. Compliance is our business.
Here is what you can do now!
•    Sign up HERE for the informational webinar Implementation of Virginia’s Temporary Infectious Disease Prevention Standard: What You Need to Succeed.
•    Bookmark the TMC page that deals specifically with this subject. We will publish information complying with the regulation as they are developed and in place.
•    Share this information with anyone you know that will be impacted, especially those who are in healthcare.

Virginia is working to get practices back in business, and there is a strong emphasis to do it safely. Total Medical Compliance (TMC) would like to assist in that effort by providing an addendum to an OSHA manual to address Respiratory Protection Plan protocols and procedures. We are providing this download free to TMC OSHA clients until 7/1/20 and at a discount for VMGMA members. Please go to our website ( and use the following code to get your VMGMA member discount:  DSM30
If you have questions, call TMC at 1-888-862-6742. Bill Fivek, President & CEO ([email protected])
Respiratory Protection Plan
With the recent events surrounding the COVID - 19 crisis, Total Medical Compliance (TMC) anticipates that there will be additional focus on how employers protect their workers from exposure to diseases spread in an airborne manner. Based on CDC guidance, practices that perform procedures which generate aerosols will require a higher level of respiratory protection, such as the N95 respirator. When implementing the use of respirators, a written plan and training must be in place to ensure the safety of the worker.  TMC has developed this written plan and in conjunction with appropriate equipment and practice involvement, your practice will have the tools needed for success.
Package Includes:
    A written Respiratory Protection Plan, customizable by the practice.  
    A webinar on completion and implementation of the plan. We plan on doing a live webinar initially, and the recorded session will be made available afterwards.
(3/21/20) Virginia Board of Nursing - To All Board Of Nursing Licensees
On March 12, 2020, Governor Northam issued Executive Order No. 51 declaring a state of emergency for the Commonwealth due to the novel COVID-19. In response to that Order, on March 19, 2020, Dr. David Brown, Director of the Department of Health Professions, waived certain Board of Nursing regulations with the goal of removing certain regulatory barriers to assist with education, testing, practice and workforce issues. Information regarding these waivers is located HERE.


  General Counsel Services Provided By



                ------DIAMOND-------       -------------GOLD--------------           --------------------SILVER----------------------